Taysha Gene Therapies Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -22,862.2% | – | – | – | – | – | |
| – | +0.0% | +5,366.7% | +138.2% | +17.0% | -9.2% | -8.0% | |
| – | – | +442.2% | -0.8% | -56.2% | +65.8% | +1.5% | |
| – | +649.6% | -3.6% | +104.6% | – | – | – | |
| – | -120.6% | – | -35.4% | -197.3% | – | – | |
| – | +10,975.6% | +137.3% | +15.4% | -70.4% | -94.9% | +97.3% | |
| – | +0.0% | +137.3% | +15.7% | -70.5% | -95.1% | +66.4% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -100.0% | – | -100.0% | – | |
| – | +0.0% | -86.6% | +33.3% | +161.8% | -43.8% | +258.1% | |
| – | +186,013.3% | -139.6% | – | – | -108.8% | – | |
| – | -29,589.6% | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.